TY - STD TI - Public Law. Orphan Drug Act of 1983. Pub L. No. 97–414, 96 Stat. 2049. Available from: https://www.fda.gov/media/99546/download. [cited 2020 Feb 25]. UR - https://www.fda.gov/media/99546/download ID - ref1 ER - TY - JOUR AU - Richter, T. AU - Janoudi, G. AU - Amegatse, W. AU - Nester-Parr, S. PY - 2018 DA - 2018// TI - Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR JO - Orphanet J Rare Dis. VL - 13 UR - https://doi.org/10.1186/s13023-018-0762-1 DO - 10.1186/s13023-018-0762-1 ID - Richter2018 ER - TY - STD TI - Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. Nat Publ Group; 2020;19:77–78. ID - ref3 ER - TY - STD TI - RARE Facts [Internet]. Glob. Genes. [cited 2020 Feb 25]. Available from: https://globalgenes.org/rare-facts/. UR - https://globalgenes.org/rare-facts/ ID - ref4 ER - TY - JOUR AU - Picavet, E. AU - Cassiman, D. AU - Hollak, C. E. AU - Maertens, J. A. AU - Simoens, S. PY - 2013 DA - 2013// TI - Clinical evidence for orphan medicinal products-a cause for concern? JO - Orphanet J Rare Dis VL - 8 UR - https://doi.org/10.1186/1750-1172-8-164 DO - 10.1186/1750-1172-8-164 ID - Picavet2013 ER - TY - JOUR AU - Wilcken, B. PY - 2001 DA - 2001// TI - Rare diseases and the assessment of intervention: what sorts of clinical trials can we use? JO - J Inherit Metab Dis VL - 24 UR - https://doi.org/10.1023/A:1010387522195 DO - 10.1023/A:1010387522195 ID - Wilcken2001 ER - TY - JOUR AU - Kempf, L. AU - Goldsmith, J. C. AU - Temple, R. PY - 2018 DA - 2018// TI - Challenges of developing and conducting clinical trials in rare disorders JO - Am J Med Genet A VL - 176 UR - https://doi.org/10.1002/ajmg.a.38413 DO - 10.1002/ajmg.a.38413 ID - Kempf2018 ER - TY - JOUR AU - Woodcock, J. AU - LaVange, L. M. PY - 2017 DA - 2017// TI - Master protocols to study multiple therapies, multiple diseases, or both JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMra1510062 DO - 10.1056/NEJMra1510062 ID - Woodcock2017 ER - TY - JOUR AU - Patterson, M. C. AU - Mengel, E. AU - Wijburg, F. A. AU - Muller, A. AU - Schwierin, B. AU - Drevon, H. PY - 2013 DA - 2013// TI - Disease and patient characteristics in NP-C patients: findings from an international disease registry JO - Orphanet J Rare Dis VL - 8 UR - https://doi.org/10.1186/1750-1172-8-12 DO - 10.1186/1750-1172-8-12 ID - Patterson2013 ER - TY - JOUR AU - Vanier, M. T. AU - Millat, G. PY - 2003 DA - 2003// TI - Niemann-Pick disease type C JO - Clin Genet VL - 64 UR - https://doi.org/10.1034/j.1399-0004.2003.00147.x DO - 10.1034/j.1399-0004.2003.00147.x ID - Vanier2003 ER - TY - JOUR AU - Pineda, M. AU - Walterfang, M. AU - Patterson, M. C. PY - 2018 DA - 2018// TI - Miglustat in Niemann-Pick disease type C patients: a review JO - Orphanet J Rare Dis. VL - 13 UR - https://doi.org/10.1186/s13023-018-0844-0 DO - 10.1186/s13023-018-0844-0 ID - Pineda2018 ER - TY - STD TI - Orphanet. Prevalence and incidence of rare diseases. [Internet]. Orphanet Rep. Ser. 2017 [cited 2020 Feb 15]. Available from: https://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. UR - https://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf ID - ref12 ER - TY - STD TI - Reference GH. Ataxia-telangiectasia [Internet]. Genet. Home Ref. [cited 2020 Feb 25]. Available from: https://ghr.nlm.nih.gov/condition/ataxia-telangiectasia. UR - https://ghr.nlm.nih.gov/condition/ataxia-telangiectasia ID - ref13 ER - TY - JOUR AU - Vibert, N. AU - Vidal, P. P. PY - 2001 DA - 2001// TI - In vitro effects of acetyl-DL-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig JO - Eur J Neurosci VL - 13 UR - https://doi.org/10.1046/j.0953-816x.2000.01447.x DO - 10.1046/j.0953-816x.2000.01447.x ID - Vibert2001 ER - TY - JOUR AU - Suh, B. -. C. AU - Hille, B. PY - 2008 DA - 2008// TI - PIP2 is a necessary cofactor for ion channel function: how and why? JO - Annu Rev Biophys VL - 37 UR - https://doi.org/10.1146/annurev.biophys.37.032807.125859 DO - 10.1146/annurev.biophys.37.032807.125859 ID - Suh2008 ER - TY - JOUR AU - Ferber-Viart, C. AU - Dubreuil, C. AU - Vidal, P. P. PY - 2009 DA - 2009// TI - Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy JO - Audiol Neurootol VL - 14 UR - https://doi.org/10.1159/000148206 DO - 10.1159/000148206 ID - Ferber-Viart2009 ER - TY - JOUR AU - Günther, L. AU - Beck, R. AU - Xiong, G. AU - Potschka, H. AU - Jahn, K. AU - Bartenstein, P. PY - 2015 DA - 2015// TI - N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamus JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0120891 DO - 10.1371/journal.pone.0120891 ID - Günther2015 ER - TY - JOUR AU - Tighilet, B. AU - Leonard, J. AU - Bernard-Demanze, L. AU - Lacour, M. PY - 2015 DA - 2015// TI - Comparative analysis of pharmacological treatments with N-acetyl-DL-leucine (Tanganil) and its two isomers (N-acetyl-L-leucine and N-acetyl-D-leucine) on vestibular compensation: behavioral investigation in the cat JO - Eur J Pharmacol VL - 769 UR - https://doi.org/10.1016/j.ejphar.2015.11.041 DO - 10.1016/j.ejphar.2015.11.041 ID - Tighilet2015 ER - TY - STD TI - te Vruchte D, Galione A, Strupp M, Mann M. Effects of N-Acetyl-Leucine and its enantiomers in Niemann-Pick disease type C cells. bioRxiv. 2019;826222. ID - ref19 ER - TY - STD TI - Sarkar C, Hegdekar N, Lipinski MM. N-acetyl-L-leucine treatment attenuates neuronal cell death and suppresses neuroinflammation after traumatic brain injury in mice. bioRxiv. 2019:759894. ID - ref20 ER - TY - JOUR AU - Bremova, T. AU - Malinová, V. AU - Amraoui, Y. AU - Mengel, E. AU - Reinke, J. AU - Kolníková, M. PY - 2015 DA - 2015// TI - Acetyl-dl-leucine in Niemann-Pick type C: a case series JO - Neurology. VL - 85 UR - https://doi.org/10.1212/WNL.0000000000002041 DO - 10.1212/WNL.0000000000002041 ID - Bremova2015 ER - TY - JOUR AU - Cortina-Borja, M. AU - Vruchte, D. AU - Mengel, E. AU - Amraoui, Y. AU - Imrie, J. AU - Jones, S. A. PY - 2018 DA - 2018// TI - Annual severity increment score as a tool for stratifying patients with Niemann-pick disease type C and for recruitment to clinical trials JO - Orphanet J Rare Dis. VL - 13 UR - https://doi.org/10.1186/s13023-018-0880-9 DO - 10.1186/s13023-018-0880-9 ID - Cortina-Borja2018 ER - TY - JOUR AU - Schniepp, R. AU - Strupp, M. AU - Wuehr, M. AU - Jahn, K. AU - Dieterich, M. AU - Brandt, T. PY - 2016 DA - 2016// TI - Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia-a case series JO - Cerebellum Ataxias VL - 3 UR - https://doi.org/10.1186/s40673-016-0046-2 DO - 10.1186/s40673-016-0046-2 ID - Schniepp2016 ER - TY - JOUR AU - Strupp, M. AU - Teufel, J. AU - Habs, M. AU - Feuerecker, R. AU - Muth, C. AU - Warrenburg, B. P. PY - 2013 DA - 2013// TI - Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series JO - J Neurol VL - 260 UR - https://doi.org/10.1007/s00415-013-7016-x DO - 10.1007/s00415-013-7016-x ID - Strupp2013 ER - TY - STD TI - Laumen A, Schneider S, Bremova-Ertl T, Kraus L, Feil K, Strupp M. Rates of responsiveness of acetyl-DL-leucine treatment for ataxia symptoms. Eur J Neurol. 2019;26. ID - ref25 ER - TY - STD TI - Churchill GC, Strupp M, Galione A, Platt FM. Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance. PLUS ONE. 2020;15(2). ID - ref26 ER - TY - JOUR AU - Carswell, C. AU - Rañopa, M. AU - Pal, S. AU - MacFarlane, R. AU - Siddique, D. AU - Thomas, D. PY - 2012 DA - 2012// TI - Video rating in neurodegenerative disease clinical trials: the experience of PRION-1 JO - Dement Geriatr Cogn Disord Extra VL - 2 UR - https://doi.org/10.1159/000339730 DO - 10.1159/000339730 ID - Carswell2012 ER - TY - JOUR AU - Handforth, A. AU - Ondo, W. G. AU - Tatter, S. AU - Mathern, G. W. AU - Simpson, R. K. AU - Walker, F. PY - 2003 DA - 2003// TI - Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trial JO - Neurology. VL - 61 UR - https://doi.org/10.1212/01.WNL.0000094355.51119.D2 DO - 10.1212/01.WNL.0000094355.51119.D2 ID - Handforth2003 ER - TY - JOUR AU - Quinn, J. AU - Moore, M. AU - Benson, D. F. AU - Clark, C. M. AU - Doody, R. AU - Jagust, W. PY - 2002 DA - 2002// TI - A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial JO - Neurology. VL - 58 UR - https://doi.org/10.1212/WNL.58.3.433 DO - 10.1212/WNL.58.3.433 ID - Quinn2002 ER - TY - JOUR AU - Lord, S. E. AU - Halligan, P. W. AU - Wade, D. T. PY - 1998 DA - 1998// TI - Visual gait analysis: the development of a clinical assessment and scale JO - Clin Rehabil VL - 12 UR - https://doi.org/10.1191/026921598666182531 DO - 10.1191/026921598666182531 ID - Lord1998 ER - TY - STD TI - Dunlop BW, Gray J, Rapaport MH. Transdiagnostic clinical global impression scoring for routine clinical settings. Behav Sci [Internet]. 2017 [cited 2020 Feb 15];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618048/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618048/ ID - ref31 ER - TY - JOUR AU - Schmitz-Hübsch, T. AU - Giunti, P. AU - Stephenson, D. A. AU - Globas, C. AU - Baliko, L. AU - Saccà, F. PY - 2008 DA - 2008// TI - SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia JO - Neurology. VL - 71 UR - https://doi.org/10.1212/01.wnl.0000324863.76290.19 DO - 10.1212/01.wnl.0000324863.76290.19 ID - Schmitz-Hübsch2008 ER - TY - JOUR AU - Subramony, S. H. PY - 2007 DA - 2007// TI - SARA--a new clinical scale for the assessment and rating of ataxia JO - Nat Clin Pract Neurol VL - 3 UR - https://doi.org/10.1038/ncpneuro0426 DO - 10.1038/ncpneuro0426 ID - Subramony2007 ER - TY - STD TI - EuroQol Group. EQ-5D Instruments | About EQ-5D. 2017. [Internet]. 2017 [cited 2020 Feb 15]. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about. UR - https://euroqol.org/eq-5d-instruments/eq-5d-5l-about ID - ref34 ER - TY - JOUR AU - Iturriaga, C. AU - Pineda, M. AU - Fernández-Valero, E. M. AU - Vanier, M. T. AU - Coll, M. J. PY - 2006 DA - 2006// TI - Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale JO - J Neurol Sci VL - 249 UR - https://doi.org/10.1016/j.jns.2006.05.054 DO - 10.1016/j.jns.2006.05.054 ID - Iturriaga2006 ER - TY - JOUR AU - Pineda, M. AU - Perez-Poyato, M. S. AU - O’Callaghan, M. AU - Vilaseca, M. A. AU - Pocovi, M. AU - Domingo, R. PY - 2010 DA - 2010// TI - Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series JO - Mol Genet Metab VL - 99 UR - https://doi.org/10.1016/j.ymgme.2009.11.007 DO - 10.1016/j.ymgme.2009.11.007 ID - Pineda2010 ER - TY - JOUR AU - Quinn, T. J. AU - Dawson, J. AU - Walters, M. R. AU - Lees, K. R. PY - 2008 DA - 2008// TI - Variability in modified Rankin scoring across a large cohort of international observers JO - Stroke. VL - 39 UR - https://doi.org/10.1161/STROKEAHA.108.515262 DO - 10.1161/STROKEAHA.108.515262 ID - Quinn2008 ER - TY - JOUR AU - Posner, K. AU - Brown, G. K. AU - Stanley, B. AU - Brent, D. A. AU - Yershova, K. V. AU - Oquendo, M. A. PY - 2011 DA - 2011// TI - The Columbia–Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults JO - Am J Psychiatry VL - 168 UR - https://doi.org/10.1176/appi.ajp.2011.10111704 DO - 10.1176/appi.ajp.2011.10111704 ID - Posner2011 ER - TY - JOUR AU - Yanjanin, N. M. AU - Vélez, J. I. AU - Gropman, A. AU - King, K. AU - Bianconi, S. E. AU - Conley, S. K. PY - 2010 DA - 2010// TI - Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C JO - Am J Med Genet Part B Neuropsychiatr Genet VL - 153B ID - Yanjanin2010 ER -